Skip to main content

Table 2 Baseline demographic and clinical characteristics in women

From: Gender differences in the relationship between serum uric acid and the long-term prognosis in heart failure: a nationwide study

 

All (N=696)

Tertile 1 (N=223)

Tertile 2 (N=235)

Tertile 3 (N=238)

Uric acid (mg/dL)

5.9 (4.8-7.1)

<5.1

5.1-6.5

>6.5

Age, years

71 (60-80)

66 (51-78)

71 (61-80) †

74 (64-80) †

Body mass index, kg/m2

30.6 (25.9-37.8)

28.6 (25.1-34.0)

31.8 (26.2-37.9) †

31.7 (27.3-40.3) †

Systolic BP, mmHg

134 (118-150)

134 (118-148)

136 (119-152)

132 (116-146)

Diastolic BP, mmHg

65 (56-74)

66 (58-74)

66 (58-76)

64 (54-72) † ‡

Heart rate, bpm

70 (62-80)

70 (64-80)

70 (62-78)

72 (62-80)

Race, n (%)

    

Non-Hispanic White

348 (50.0)

113 (50.7)

114 (48.5)

121 (50.8)

No-Hispanic Black

188 (27.0)

49 (22.0)

63 (26.8)

76 (31.9) †

Mexican American

81 (11.6)

32 (14.3)

35 (14.9)

14 (5.9) †‡

Other

79 (11.4)

29 (13.0)

23 (9.8)

27 (11.4)

History of smoking, n (%)

333 (47.8)

104 (46.6)

122 (51.9)

107 (45.0)

History of drinking, n (%)

306 (44.0)

100 (44.8)

109 (46.4)

97 (40.8)

Hypertension, n (%)

594 (85.3)

178 (79.8)

206 (87.7) †

210 (88.2) †

Diabetes mellitus, n (%)

312 (44.8)

90 (40.4)

95 (40.4)

127 (53.4) †‡

Coronary heart disease, n (%)

209 (30.0)

69 (30.9)

69 (29.4)

71 (29.8)

Stroke, n (%)

148 (21.3)

52 (23.3)

44 (18.7)

52 (21.8)

Laboratory tests

    

WBC, 103/uL

7.2 (5.9-8.8)

7.1 (5.9-8.4)

7.1 (5.9-9.0)

7.4 (6.1-8.8)

Hemoglobin, g/dL

12.7 (11.4-13.7)

12.9 (11.4-13.7)

12.9 (11.9-13.9)

12.3 (11.3-13.5) † ‡

Albumin, g/L

40.0 (38.0-42.0)

40.0 (38.0-42.0)

40.0 (38.0-42.0)

40.0 (38.0-42.0)

HbA1c, %

5.9 (5.5-6.7)

5.8 (5.4-6.5)

5.9 (5.6-6.6) †

6.1 (5.6-7.1) † ‡

Total cholesterol, mmol/L

4.8 (4.0-5.6)

4.9 (3.9-5.8)

5.0 (4.2-5.8)

4.6 (3.8-5.3) ‡

Triglyceride, mg/dL

135.0 (95.0-195.0)

122.0 (82.0-186.0)

141.0 (102.0-194.0) †

137.5 (104.0-202.5) †

Serum glucose, mg/dL

102.0 (91.3-129.0)

99.0 (88.0-120.0)

100.0 (90.0-123.0)

107.0 (94.0-140.3) † ‡

eGFR, mL/min/1.73m2

77.1 (49.7-99.9)

94.1 (69.9-109.8)

79.3 (59.6-98.4) †

53.9 (36.7-81.4) † ‡

Serum sodium, mmol/L

139.0 (137.9-141.0)

139.0 (137.0-141.0)

140.0 (138.0-142.0) †

139.6 (138.0-141.8) †

Serum potassium, mmol/L

4.1 (3.8-4.4)

4.0 (3.7-4.3)

4.1 (3.8-4.3) †

4.2 (3.9-4.5) †

Serum chloride, mmol/L

102.0 (100.0-105.0)

102.0 (99.0-105.0)

103.0 (100.0-105.0)

102.0 (100.0-105.0)

Medication

    

ACEI/ARB, n (%)

373 (53.6)

103 (46.2)

134 (57.0) †

136 (57.1) †

Beta blockers, n (%)

357 (51.3)

91 (40.8)

125 (53.2) †

141 (59.2) †

MRA, n (%)

62 (8.9)

9 (4.0)

20 (8.5) †

33 (13.9) †

Diuretics, n (%)

378 (54.3)

81 (36.3)

121 (51.5) †

176 (73.9) †‡

Urate-lowering agents, n (%)

28 (4.0)

10 (4.5)

6 (2.6)

12 (5.0)

  1. Values are presented as median (interquartile range), or n (%). For P-value, † indicates p value < 0.05 versus Tertile 1, ‡ indicates p value < 0.05 versus Tertile 2
  2. Abbreviations: ACE-I, angiotensin-converting inhibitor; ARB, angiotensin II receptor blocker; BP, blood pressure; eGFR, the rate of estimated glomerular filtration rate; Hb1Ac, hemoglobin A1c; MRA, mineralocorticoid-receptor antagonist; WBC, white blood cells